Menu
Search icon
  1. Home Page
    2. ›
  2. Counties
    3. ›
  3. Albany
    4. ›
  4. 12206
    5. ›
  5. ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES

ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES

Company Details

Name: ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES
Jurisdiction: New York
Legal type: DOMESTIC NOT-FOR-PROFIT CORPORATION
Status: Active
Date of registration: 30 Aug 1881 (144 years ago)
Entity Number: 15641
ZIP code: 12206
County: Albany
Place of Formation: New York
Address: 106 NEW SCOTLAND AVENUE, ALBANY, NY, United States, 12206

DOS Process Agent

Name Role Address
THE CORPORATION DOS Process Agent 106 NEW SCOTLAND AVENUE, ALBANY, NY, United States, 12206

Unique Entity ID

A UEI is a government-provided number, like a tax ID number, that’s used to identify businesses eligible for federal grants, awards and contracts.

Note: In April 2022, the federal government replaced its old identifier of choice, the Data Universal Numbering System (DUNS) number, with a government-issued UEI. Now all the federal government’s Integrated Award Environment systems use UEI numbers instead of DUNS numbers. So any entity doing business with the federal government must register for a UEI.

Unique Entity ID:
LCFLMPUNNGJ3
CAGE Code:
1M9T7
UEI Expiration Date:
2025-07-30

Business Information

Doing Business As:
ALBANY COLLEGE OF PHARMACY & HEALTH SCIENCES
URL:
acphs.edu
Activation Date:
2024-08-01
Initial Registration Date:
2001-09-05

Commercial and government entity program

The The Commercial And Government Entity Code (CAGE) is assigned by the Department of Defense's Defense Logistics Agency (DLA) and represents your company's physical address for GSA's mailings, payments, and administrative records.

Note: A CAGE Code enables a company to contract with the U.S. government, allowing bid on government contracts and to receive government payments. Also for business this means that it's a Verified business entity and Has a validated physical address.

CAGE number:
1M9T7
Status:
Active
Type:
Non-Manufacturer
CAGE Update Date:
2024-08-01
CAGE Expiration:
2029-08-01
SAM Expiration:
2025-07-30

Contact Information

POC:
MICHELE D. VIEN
Phone:
+1 518-694-7216
Fax:
+1 518-694-7202

National Provider Identifier

NPI Number:
1710420294
Link:
View on NPI website

Authorized Person:

Name:
DAVID KILE
Role:
EXECUTIVE DIRECTOR OF CEPD
Phone:
5186947346

Taxonomy:

Selected Taxonomy:
3336C0003X - Community/Retail Pharmacy
Is Primary:
No
Selected Taxonomy:
333600000X - Pharmacy
Is Primary:
No
Selected Taxonomy:
3336C0003X - Community/Retail Pharmacy
Is Primary:
Yes

Contacts:

Phone:
+1 518-694-8522
Fax:
5186948523

Form 5500 Series

Employer Identification Number (EIN):
141423161
Plan Year:
2014
Number Of Participants:
273
File:
View File
Plan Year:
2013
Number Of Participants:
247
Sponsors Telephone Number:
5186947200
File:
View File
Plan Year:
2012
Number Of Participants:
267
Sponsors Telephone Number:
5186947200
File:
View File
Plan Year:
2011
Number Of Participants:
266
Sponsors Telephone Number:
5186947200
File:
View File
Plan Year:
2010
Number Of Participants:
241
Sponsors Telephone Number:
5184457200
File:
View File

Filings

Filing Number Date Filed Type Effective Date
080821000841 2008-08-21 CERTIFICATE OF AMENDMENT 2008-08-21
B236715-2 1985-06-13 ASSUMED NAME CORP INITIAL FILING 1985-06-13
248002 1961-01-03 CERTIFICATE OF ANNULMENT OF DISSOLUTION AND REINSTATEMENT OF CORPORATE EXISTENCE 1961-01-03
DP-136 1952-10-15 DISSOLUTION BY PROCLAMATION 1952-10-15
18P-149 1881-08-30 CERTIFICATE OF INCORPORATION 1881-08-30

USAspending Awards / Contracts

Procurement Instrument Identifier:
75F40122C00125
Link:
View Award on USAspending website
Award Or Idv Flag:
AWARD
Award Type:
DEFINITIVE CONTRACT
Awarding Agency Name:
Department of Health and Human Services
Performance Start Date:
2022-09-16
Total Dollars Obligated:
1292592.52
Current Total Value Of Award:
1292592.52
Potential Total Value Of Award:
1899949.54
Description:
MRNA BASED VACCINES TRAINING
Naics Code:
541714: RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
Product Or Service Code:
U004: EDUCATION/TRAINING- SCIENTIFIC/MANAGEMENT
Procurement Instrument Identifier:
HHSF223201510132C
Link:
View Award on USAspending website
Award Or Idv Flag:
AWARD
Award Type:
DEFINITIVE CONTRACT
Awarding Agency Name:
Department of Health and Human Services
Performance Start Date:
2015-09-11
Total Dollars Obligated:
199380.68
Current Total Value Of Award:
199380.68
Potential Total Value Of Award:
199380.68
Description:
IGF::CL::IGF BAA TITLED, "A COMMUNITY BASED STUDY OF ADVERSE EFFECTS OF NSAIDS ON THE KIDNEY AND RISK MITIGATION TO REDUCE PREVENTABLE HARM"
Naics Code:
541712: RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
Product Or Service Code:
AZ11: R&D- OTHER RESEARCH AND DEVELOPMENT (BASIC RESEARCH)
Procurement Instrument Identifier:
V528D95010
Link:
View Award on USAspending website
Award Or Idv Flag:
AWARD
Award Type:
PO
Awarding Agency Name:
Department of Veterans Affairs
Performance Start Date:
2009-01-01
Description:
SMALL PURCHASE DATA
Product Or Service Code:
R699: OTHER ADMINISTRATIVE SUPPORT SVCS

USAspending Awards / Financial Assistance

Date:
2025-04-10
Link:
View on USAspending
Awarding Agency Name:
Department of Education
Transaction Description:
CAMPUS BASED-FSEOG
Obligated Amount:
67040.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2025-04-10
Link:
View on USAspending
Awarding Agency Name:
Department of Education
Transaction Description:
CAMPUS BASED-FWS
Obligated Amount:
250000.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2025-04-03
Link:
View on USAspending
Awarding Agency Name:
Department of Education
Transaction Description:
2025-2026 DL BASE RECORD
Obligated Amount:
0.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2025-02-19
Link:
View on USAspending
Awarding Agency Name:
Department of Education
Transaction Description:
PELL GRANTS
Obligated Amount:
1000.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2025-01-23
Link:
View on USAspending
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
INVESTIGATING RNA POLYMERASE III DRIVEN MECHANISMS IN REGULATING HIV LATENCY - ABSTRACT RESTING CD4+ T CELLS HARBOR MAJORITY OF LATENT HUMAN IMMUNODEFICIENCY VIRUS (HIV) DURING INFECTION. ELIMINATION OF THIS RESERVOIR IS AN EXTREMELY CHALLENGING TASK BECAUSE OF INVOLVEMENT OF MULTIPLE MECHANISMS IN REGULATING HIV LATENCY. THEREFORE, PERHAPS, NONE OF THE CURRENTLY PROMISING LATENCY REVERSING AGENTS (LRAS) WERE ABLE TO REDUCE THE SIZE OF THE LATENT PROVIRAL RESERVOIR IN PATIENTS. HENCE, THERE IS A DIRE NEED TO FIND NOVEL MECHANISMS AND THERAPEUTIC TARGETS THAT CAN BE TARGETED TO PURGE THE HETEROGENOUS LATENT RESERVOIR. RNA POLYMERASE III (RNA POL III) APPEARS TO BE A MASTER REGULATOR WITH UNEXPLORED POTENTIAL OF REGULATING LATENCY VIA MEDIATING DISTINCT MECHANISMS, SUCH AS I) REGULATING THE EXPRESSION FROM NEIGHBORING RNA POL II GENE PROMOTERS AND II) TRANSCRIPTION OF NOVEL NONCODING RNAS WITH POTENTIAL TO REGULATE EXPRESSION OF CELLULAR/VIRAL GENES. OUR PRELIMINARY STUDIES SUGGEST THE ENRICHMENT OF POL III TRANSCRIBED NONCODING RNAS IN LATENT CELLS, NAMELY 7SK, 21A AND BC200 THAT ARE INTERSPERSED AMONG ALU REPEATS. THIS IS HIGHLY RELEVANT TO HIV LATENCY BECAUSE THE HIV GENOME IS FOUND TO PREFERENTIALLY INTEGRATE NEAR ALU REPEATS. CONSEQUENTLY, USE OF AN RNA POL III INHIBITOR, ML60218, RESULTED IN AN UNPRECEDENTED REACTIVATION (UP TO 90%) OF LATENT CELL LINES J89GFP AND THP89GFP, IN A DOSE- DEPENDENT MANNER (25 ΜM-50 ΜM). FURTHER, WE OBSERVED A HIGH DEGREE OF CELL DEATH SPECIFICALLY IN HIV INFECTED CELLS DUE TO VIRAL CYTOPATHIC EFFECTS, WHEREAS UNINFECTED CELLS MAINTAINED SURVIVAL EVEN AT A VERY HIGH CONCENTRATION OF RNA POL III INHIBITOR (100 ΜM). THESE EXCITING FINDINGS AND CORROBORATING REPORTS WILL BE LEVERAGED TO TEST THE HYPOTHESIS THAT RNA POL III PLAYS A CRUCIAL ROLE IN THE ESTABLISHMENT OF HIV LATENCY AND TARGETING NOVEL INTERMEDIATE EFFECTORS OF RNA POL III DRIVEN MECHANISMS MAY ENHANCE THE EFFICACY OF CURE STRATEGIES. THIS STUDY IS DIVIDED INTO TWO SPECIFIC AIMS THAT WILL BE FOCUSED ON INVESTIGATING RNA POL III DRIVEN DIRECT (BY GENOMIC OCCUPANCY) AND INDIRECT (BY NCRNAS) MECHANISMS THAT MAY REGULATE HIV LATENCY. IN AIM 1, EFFECT OF RNA POL III INHIBITION/KNOCKDOWN WILL BE TESTED IN EX VIVO CULTURED PRIMARY CD4+ T CELL MODEL. FURTHER IN AIM 1.2 WE WILL INVESTIGATE IF PHYSICAL PRESENCE OF RNA POL III IN PROXIMITY CAN MODIFY CHROMATIN LANDSCAPE AT HIV 5´ LTR. IN AIM 2, WE WILL IDENTIFY RNA POL III TRANSCRIBED NONCODING RNAS INVOLVED IN LATENCY BY EMPLOYING RNA-SEQ IN COMBINATION WITH RNA POL III CHIP-SEQ. FINALLY, GENE KNOCKDOWN STUDIES WILL BE PERFORMED FOR SELECT NONCODING RNAS ALONE OR IN COMBINATION TO INVESTIGATE THEIR ROLE IN PROMOTING REPRESSED CHROMATIN STATE AT HIV 5´ LTR. OUR STUDY IS HIGHLY INNOVATIVE AS WE AIM TO IDENTIFY NOVEL EPIGENETIC MODULATORS THAT CAN BE SYNCHRONOUSLY TARGETED TO OVERCOME CHALLENGES ASSOCIATED WITH SHOCK AND KILL STRATEGY OF HIV CURE. SUCCESSFUL COMPLETION OF THIS STUDY WILL PROVIDE CRITICAL MECHANISTIC INFORMATION WHICH MAY ADDRESS THE HETEROGENEITY AMONG LATENT RESERVOIRS.
Obligated Amount:
495321.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00

Tax Exempt

Employer Identification Number (EIN) :
14-1423161
Classification:
Educational Organization, Local Association of Employees, Horticultural Organization, Business League, Voluntary Employees' Beneficiary Association (Govt. Emps.), Mutual Ditch or Irrigation Co., Cemetery Company, Other Mutual Corp. or Assoc.
Ruling Date:
1926-03
Deductibility:
Type of organization and use of contribution: A public charity. Deductibility Limitation: 50% (60% for cash contributions)

Related by officers

THE CORPORATION

ARSHIA DESIGNS INC. AAA VACUUM CORP. ATLANTICA TELECOM, INC. MISTY SPORTSWEAR, INC. FAT JAMS ELECTRONICS INC. CROQUEMBOUCHE, INC. LONG BEACH PEDIATRIC GROUP, P.C. LAW OFFICES OF JOSEPH A. GRECO, P.C. TEREZ, INC. 732 CINNAMON BEACH INC.

Related by address

No related companies by address

Date of last update: 19 Mar 2025

Sources: New York Secretary of State

Privacy policy Policy
About us About us
Contacts Contact us

© 2025 bizyork.com, Part of Big Data Integrated